In today's complex clinical landscape, sponsors face mounting pressure to accelerate timelines, reduce risk, and improve trial outcomes. IQVIA's latest white paper, Innovate with Greater Confidence and Focus, explores how cutting-edge technologies—like Healthcare-grade AI®, generative AI, and agentic AI—are reshaping the future of clinical development. This white paper is part two of a four-part series spotlighting innovation in clinical research. It offers actionable insights for clinical operations leaders, trial designers, and regulatory strategists looking to:
Authored by IQVIA experts Raja Shankar and Stephen Hampton.
Enhance patient safety and study quality by using data, analytics, and technology to monitor patient, site, and study performance with risk-based and centralized monitoring.
Explore our end-to-end, full service clinical development capabilities including Therapeutics expertise, Development Planning, Phase I early clinical development, Phase IIb/III and Phase IV Trials, Regulatory Submission and Post-Launch Studies.
.svg){kind=icon}
